Funded pharmacy vaccination of pregnant women: uptake and views and experiences
- Conditions
- VaccinationPertussisInfluenzaPregnancyInfection - Other infectious diseasesPublic Health - Health service researchReproductive Health and Childbirth - Antenatal care
- Registration Number
- ACTRN12616001453471
- Lead Sponsor
- Dr Natalie Gauld
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 27000
Women who were pregnant during the observed period, are NZ residents, were eligible for the vaccinations during the study period, and have a surviving fetus beyond 27 weeks.
Note: women will not be enrolled as such for the primary outcome, and data will only be used for women who had the vaccinations and had a surviving fetus beyond 27 weeks. Women will be eligible for the vaccinations if pregnant but if they do not have a surviving fetus beyond 27 weeks will not be included.
For the secondary qualitative research, women will be invited to participate in an interview and only with informed consent will the interview progress.
Women who deliver before 27 weeks, or who do not deliver a live baby. Women who are not eligible for funded vaccines (e.g. not NZ residents).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of influenza vaccinations in pregnant women both overall and by delivery location (general practice, hospital, pharmacy). Measured through vaccination data collected in National Immunisation Record and claims data[24 months after 1 Nov 2016 ];Number of pertussis vaccinations in pregnant women both overall and by delivery location (general practice, hospital, pharmacy). Measured through vaccination data collected in National Immunisation Record and claims data[24 months after 1 Nov 2016];Number of influenza and pertussis vaccinations in pregnant women both overall and by delivery location (general practice, hospital, pharmacy). Measured through vaccination data collected in National Immunisation Record and claims data over a 3-3.5 year period[3-3.5 years after the intervention started]
- Secondary Outcome Measures
Name Time Method